Changes in Circulating Levels of 25-hydroxyvitamin D3 in Breast Cancer Patients Receiving Chemotherapy

References

• Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, et al.: Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep), Report no. 158, 1–235, 2007.
   PubMedGoogle Scholar
• Chung M, Balk EM, Brendel M, Ip S, Lau J, et al.: Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep), Report no. 183, 1–420, 2009.
   PubMedGoogle Scholar
• Cranney A, Weiler HA, O'Donnell S, and Puil L: Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88, 513S–519s, 2008.
   PubMed Web of Science ®Google Scholar
• Martin-Herranz A and Salinas-Hernandez P: Vitamin D supplementation review and recommendations for women diagnosed with breast or ovary cancer in the context of bone health and cancer prognosis/risk. Crit Rev Oncol Hematol 96,91–99, 2015.
   PubMed Web of Science ®Google Scholar
• Abdel-Razeq H and Awidi A: Bone health in breast cancer survivors. J Cancer Res Ther 7,256–263, 2011.
   PubMed Web of Science ®Google Scholar
• Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, et al.: Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 165,552–558, 2005.
   PubMed Web of Science ®Google Scholar
• Vrieling A, Seibold P, Johnson TS, Heinz J, Obi N, et al.: Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: influence of tumor characteristics and lifestyle factors? Int J Cancer 134,2972–2983, 2014.
   PubMed Web of Science ®Google Scholar
• Kim Y and Je Y: Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer 110,2772–2784, 2014.
   PubMed Web of Science ®Google Scholar
• Rose AA, Elser C, Ennis M, and Goodwin PJ: Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. Breast Cancer Res Treat 141, 331–339, 2013.
   PubMed Web of Science ®Google Scholar
• Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, et al.: Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study. JAMA Oncol 3,351–357, 2017.
   PubMed Web of Science ®Google Scholar
• Vaughan-Shaw PG, O'Sullivan F, Farrington SM, Theodoratou E, Campbell H, et al.: The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer 116,1092–1110, 2017.
   PubMed Web of Science ®Google Scholar
• Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, et al.: Vitamin D: Do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int 24,1567–1577, 2013.
   PubMed Web of Science ®Google Scholar
• Holick MF: The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18, 153–165, 2017.
   PubMed Web of Science ®Google Scholar
• Aguirre M, Manzano N, Salas Y, Angel M, Díaz-Couselo FA, et al.: Vitamin D deficiency in patients admitted to the general ward with breast, lung, and colorectal cancer in Buenos Aires, Argentina. Arc Osteoporos 11, 1–4, 2016.
   PubMed Web of Science ®Google Scholar
• Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, et al.: High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. Jco 27, 2151–2156, 2009.
   PubMed Web of Science ®Google Scholar
• Hauser K, Walsh D, Shrotriya S, and Karafa M: Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg? Support Care Cancer 22, 1931–1939, 2014.
   PubMed Web of Science ®Google Scholar
• Jacot W, Pouderoux S, Thezenas S, Chapelle A, Bleuse JP, et al.: Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat 134,709–717, 2012.
   PubMed Web of Science ®Google Scholar
• Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, et al.: Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis 33,1319–1326, 2012.
   PubMed Web of Science ®Google Scholar
• Janbabai G, Shekarriz R, Hassanzadeh H, Aarabi M, and Borhani SS: A survey on the relationship between serum 25-hydroxy vitamin D level and tumor characteristics in patients with breast cancer. Int J Hematol-Oncol Stem Cell Res 10, 30–36, 2016.
   PubMedGoogle Scholar
• Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, et al.: Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One 6,e17251, 2011.
   PubMed Web of Science ®Google Scholar
• Imtiaz S, Siddiqui N, Raza SA, Loya A, and Muhammad A: Vitamin D deficiency in newly diagnosed breast cancer patients. Indian J Endocr Metab 16, 409–413, 2012.
   PubMedGoogle Scholar
• Charehbili A, Hamdy NA, Smit VT, Kessels L, van Bochove A, et al.: Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: data from the NEOZOTAC trial (BOOG 10-01). Breast 25, 69–74, 2016.
   PubMed Web of Science ®Google Scholar
• Safaei-Nodehi R, Esmaili J, Sharifian R, Movaseghi S, and Parkhideh S: Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer? Caspian J Intern Med 8, 91–98, 2017.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Koh BS, Yu JH, Lee JW, Son BH, et al.: Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients. Eur J Cancer 50,1403–1411, 2014.
   PubMed Web of Science ®Google Scholar
• Kailajarvi ME, Salminen EK, Paija OM, Virtanent AM, Leino AE, et al.: Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy. Anticancer Res 24, 1271–1274, 2004.
   PubMed Web of Science ®Google Scholar
• de Vries YC, van den Berg MM, de Vries JH, Boesveldt S, de Kruif JT, et al.: Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer. Support Care Cancer 28, 2581–2591, 2017.
   Web of Science ®Google Scholar
• van den Ouweland JM, Beijers AM, and van Daal H: Overestimation of 25-hydroxyvitamin D3 by increased ionisation efficiency of 3-epi-25-hydroxyvitamin D3 in LC-MS/MS methods not separating both metabolites as determined by an LC-MS/MS method for separate quantification of 25-hydroxyvitamin D3, 3-epi-25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 967, 195–202, 2014.
   PubMed Web of Science ®Google Scholar
• de Hollander EL, Zwart L, de Vries SI, and Wendel-Vos W: The SQUASH was a more valid tool than the OBiN for categorizing adults according to the Dutch physical activity and the combined guideline. J Clin Epidemiol 65, 73–81, 2012.
   PubMed Web of Science ®Google Scholar
• Wendel-Vos GC, Schuit AJ, Saris WH, and Kromhout D: Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 56, 1163–1169, 2003.
   PubMed Web of Science ®Google Scholar
• Šidák Z: Rectangular confidence regions for the means of multivariate normal distributions. J Am Statis Assoc 62, 626–633, 1967.
   Web of Science ®Google Scholar
• Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, and Clipp E: Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88, 674–684, 2000.
   PubMed Web of Science ®Google Scholar
• Heaney RP, Davies KM, Chen TC, Holick MF, and Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77, 204–210, 2003.
   PubMed Web of Science ®Google Scholar
• Rapuri PB, Gallagher JC, and Haynatzki G: Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter. Calcif Tissue Int 74, 150–156, 2004.
   PubMed Web of Science ®Google Scholar
• Velicer CM and Ulrich CM: Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 26,665–673, 2008.
   PubMed Web of Science ®Google Scholar
• Pouchieu C, Fassier P, Druesne-Pecollo N, Zelek L, Bachmann P, et al.: Dietary supplement use among cancer survivors of the NutriNet-Santé cohort study. Br J Nutr 113, 1319–1329, 2015.
   PubMed Web of Science ®Google Scholar
• Velentzis LS, Keshtgar MR, Woodside JV, Leathem AJ, Titcomb A, et al.: Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study. Breast Cancer Res Treat 128, 473–482, 2011.
   PubMed Web of Science ®Google Scholar
• Alfano CM, Day JM, Katz ML, Herndon JE, 2nd, Bittoni MA, et al.: Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804. Psychooncology 18, 128–133, 2009.
   PubMed Web of Science ®Google Scholar
• Steinhilper L, Geyer S, and Sperlich S: Health behavior change among breast cancer patients. Int J Public Health 58, 603–613, 2013.
   PubMed Web of Science ®Google Scholar
• Welsh J: Function of the vitamin D endocrine system in mammary gland and breast cancer. Mol Cell Endocrinol 453, 88–95, 2017.
   PubMed Web of Science ®Google Scholar
• Welsh J: Vitamin D and breast cancer: Past and present. J Ster Biochem Mol Biol 177, 15–20, 2018.
   Web of Science ®Google Scholar
• Matilainen JM, Malinen M, Turunen MM, Carlberg C, and Väisänen S: The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J Biol Chem 285, 24174–24183, 2010.
   PubMed Web of Science ®Google Scholar
• Kemmis CM and Welsh J: Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem 105,980–988, 2008.
   PubMed Web of Science ®Google Scholar
• Marik R, Fackler M, Gabrielson E, Zeiger MA, Sukumar S, et al.: DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther 10, 44–53, 2010.
   PubMed Web of Science ®Google Scholar
• Rossdeutscher L, Li J, Luco A-L, Fadhil I, Ochietti B, et al.: Chemoprevention activity of 25-hydroxyvitamin D in the MMTV-PyMT mouse model of breast cancer. Cancer Prevent Res 8, 120–128, 2015.
   PubMed Web of Science ®Google Scholar